{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:09:41Z","timestamp":1790647781739,"version":"4.1.0"},"reference-count":70,"publisher":"Wiley","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EFS2","EFSA Journal"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.2903\/j.efsa.2017.5017","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T09:41:11Z","timestamp":1509097271000},"source":"Crossref","is-referenced-by-count":37,"title":["ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food\u2010producing animals"],"prefix":"10.2903","volume":"15","author":[{"name":"ECDC, EFSA Panel on Biological Hazards (BIOHAZ)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EMA Committee for Medicinal Products for Veterinary Use (CVMP)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.2903\/j.efsa.2017.5017_ref1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/dkr459","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref2","unstructured":"ANSES\u2010ANMV (French Agency for Food Environmental and Occupational Health & Safety, French Agency for Veterinary Medicinal Products), M\u00e9heust D, Chevance A and Moulin G 2016. Sales survey of veterinary medicinal products containing antimicrobials in France in 2015. French Agency for Food, Environmental and Occupational Health & Safety (ANSES) \u2010 French Agency for Veterinary Medicinal Products (ANMV). 105 pp. Available online: https:\/\/www.anses.fr\/en\/system\/files\/ANMV-Ra-Antibiotiques2015EN.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref3","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1017\/S0950268813002665","article-title":"Antimicrobial resistance in commensal Escherichia coli in veal calves is associated with antimicrobial drug use","volume":"142","author":"Bosman","year":"2014","journal-title":"Epidemiology and Infection"},{"key":"10.2903\/j.efsa.2017.5017_ref4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10096-013-1862-4","article-title":"Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals","volume":"32","author":"Buyle","year":"2013","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.2903\/j.efsa.2017.5017_ref5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0020-1383(11)70125-5","article-title":"MRSA prevention strategies and current guidelines","volume":"42","author":"Byrne","year":"2011","journal-title":"Injury\u2010International Journal of the Care of the Injured"},{"key":"10.2903\/j.efsa.2017.5017_ref6","doi-asserted-by":"crossref","unstructured":"Carmo LP, Schupbach\u2010Regula G, Muntener C, Chevance A, Moulin G and Magouras I, 2017. Approaches for quantifying antimicrobial consumption per animal species based on national sales data: a Swiss example, 2006 to 2013. Eurosurveillance, 22, https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.6.30458","DOI":"10.2807\/1560-7917.ES.2017.22.6.30458"},{"key":"10.2903\/j.efsa.2017.5017_ref7","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1128\/AAC.00354-08","article-title":"Selection and persistence of CTX\u2010M\u2010producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome","volume":"52","author":"Cavaco","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkt443","article-title":"Correlation between veterinary antimicrobial use and antimicrobial resistance in food\u2010producing animals: a report on seven countries","volume":"69","author":"Chantziaras","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.meegid.2011.06.001","article-title":"Genetic evolution and clinical impact in extended\u2010spectrum beta\u2010lactamase\u2010producing Escherichia coli and Klebsiella pneumoniae","volume":"11","author":"Chong","year":"2011","journal-title":"Infection Genetics and Evolution"},{"key":"10.2903\/j.efsa.2017.5017_ref10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MCP.0000000000000262","article-title":"What is the clinical relevance of drug\u2010resistant pneumococcus?","volume":"22","author":"Cilloniz","year":"2016","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.2903\/j.efsa.2017.5017_ref11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/qshc.2006.021121","article-title":"European Surveillance of antimicrobial consumption (ESAC): quality indicators for outpatient antibiotic use in Europe","volume":"16","author":"Coenen","year":"2007","journal-title":"Quality and Safety in Health Care"},{"key":"10.2903\/j.efsa.2017.5017_ref12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/zph.12298","article-title":"Guidance on the selection of appropriate indicators for quantification of antimicrobial usage in humans and animals","volume":"64","author":"Collineau","year":"2017","journal-title":"Zoonoses Public Health"},{"key":"10.2903\/j.efsa.2017.5017_ref13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrmicro.2017.28","article-title":"Next\u2010generation approaches to understand and combat the antibiotic resistome","volume":"15","author":"Crofts","year":"2017","journal-title":"Nature Reviews. Microbiology"},{"key":"10.2903\/j.efsa.2017.5017_ref14","unstructured":"ECDC (European Centre for Disease Prevention and Control), 2014. Surveillance of antimicrobial consumption in Europe 2012. Stockholm: ECDC. 82 pp. Available online: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/antimicrobial-consumption-europe-esac-net-2012.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref15","unstructured":"ECDC (European Centre for Disease Prevention and Control), 2015. Best practices in ranking emerging infectious disease threats. A literature review. Stockholm: ECDC. 43 pp. Available online: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/emerging-infectious-disease-threats-best-practices-ranking.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref16","unstructured":"ECDC (European Centre for Disease Prevention and Control), 2016. Summary of the latest data on antibiotic consumption in the European Union. ESAC\u2010Net surveillance data. November 2016. Stockholm: ECDC. 11 pp. Available online: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/antibiotics-ESAC-Net%20Summary%202016_0.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref17","unstructured":"ECDC (European Centre for Disease Prevention and Control), 2017a. ECDC tool for the prioritisation of infectious disease threats \u2013 handbook and manual. Stockholm: ECDC. 27 pp. Available online: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/Tool-for-disease-priority-ranking_handbook_0_0.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref18","unstructured":"ECDC (European Centre for Disease Prevention and Control), 2017b. Proposals for EU guidelines on the prudent use of antimicrobials in humans. Stockholm: ECDC. 22 pp. Available online: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/EU-guidelines-prudent-use-antimicrobials.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref19","unstructured":"ECDC (European Centre for Disease Prevention and Control), 2017c. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS\u2010Net). Stockholm: ECDC. 120 pp. Available online: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/antimicrobial-resistance-europe-2015.pdf"},{"issue":"1","key":"10.2903\/j.efsa.2017.5017_ref20","first-page":"4006","article-title":"ECDC\/EFSA\/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food\u2010producing animals. Stockholm\/Parma\/London: ECDC\/EFSA\/EMA, 2015","volume":"13","author":"ECDC, EFSA and EMA","year":"2015","journal-title":"EFSA Journal"},{"issue":"7","key":"10.2903\/j.efsa.2017.5017_ref21","first-page":"4872","article-title":"ECDC\/EFSA\/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food\u2010producing animals \u2013 Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) Report","volume":"15","author":"ECDC, EFSA and EMA","year":"2017","journal-title":"EFSA Journal"},{"key":"10.2903\/j.efsa.2017.5017_ref22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IDR.S55778","article-title":"Agriculture and food animals as a source of antimicrobial\u2010resistant bacteria","volume":"8","author":"Economou","year":"2015","journal-title":"Infection and Drug Resistance"},{"issue":"10","key":"10.2903\/j.efsa.2017.5017_ref23","first-page":"2897","article-title":"Technical specifications on the harmonised monitoring and reporting of antimicrobial resistance in methicillin\u2010resistant Staphylococcus aureus in food\u2010producing animals and food","volume":"10","author":"EFSA","year":"2012","journal-title":"EFSA Journal"},{"issue":"6","key":"10.2903\/j.efsa.2017.5017_ref24","first-page":"2742","article-title":"Technical specifications on the harmonised monitoring and reporting of antimicrobial resistance in Salmonella, Campylobacter and indicator Escherichia coli and Enterococcus spp. bacteria transmitted through food","volume":"10","author":"EFSA","year":"2012","journal-title":"EFSA Journal"},{"issue":"8","key":"10.2903\/j.efsa.2017.5017_ref25","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2903\/j.efsa.2011.2322","article-title":"Scientific Opinion on the public health risks of bacterial strains producing extended\u2010spectrum \u03b2\u2010lactamases and\/or AmpC \u03b2\u2010lactamases in food and food\u2010producing animals","volume":"9","author":"EFSA BIOHAZ Panel","year":"2011","journal-title":"EFSA Journal"},{"issue":"2","key":"10.2903\/j.efsa.2017.5017_ref26","first-page":"4380","article-title":"The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014","volume":"14","author":"EFSA and ECDC","year":"2016","journal-title":"EFSA Journal"},{"issue":"2","key":"10.2903\/j.efsa.2017.5017_ref27","first-page":"4694","article-title":"The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015","volume":"15","author":"EFSA and ECDC","year":"2017","journal-title":"EFSA Journal"},{"issue":"1","key":"10.2903\/j.efsa.2017.5017_ref28","first-page":"4666","article-title":"EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobialagents in animal husbandry in the European Union, and the resulting impacts on food safety(RONAFA). [EMA\/CVMP\/570771\/2015]","volume":"15","author":"EMA and EFSA","year":"2017","journal-title":"EFSA Journal"},{"key":"10.2903\/j.efsa.2017.5017_ref29","unstructured":"EMA\/AMEG (European Medicines Agency\/Antimicrobial Advice ad hoc Expert Group), 2014. Request for scientific advice on the impact on public health and animal health of the use of antibiotics in animals (AMEG) \u2010 answer to the second, third and fourth request from the European Commission (EMA\/381884\/2014). 83 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2014\/07\/WC500170253.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref30","unstructured":"EMA\/AMEG (European Medicines Agency\/Antimicrobial Advice Ad Hoc Expert Group), 2016. Updated advice on the use of colistin products in animals within the European Union: development of resistance and possible impact on human and animal health (EMA\/CVMP\/CHMP\/231573\/2016). 56 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2016\/07\/WC500211080.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref31","unstructured":"EMA\/CVMP (European Medicines Agency\/Committee for Medicinal Products for Veterinary Use), 2016. CVMP strategy on antimicrobials 2016\u20132020 (EMA\/CVMP\/209189\/2015). 16 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2016\/10\/WC500214901.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref32","unstructured":"EMA\/ESVAC (European Medicines Agency\/European Surveillance of Veterinary Antimicrobial Consumption), 2011. Trends in the sales of veterinary antimicrobial agents in nine European countries. Reporting period: 2005\u20132009. First ESVAC report. 77 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/09\/WC500112309.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref33","unstructured":"EMA\/ESVAC (European Medicines Agency\/European Surveillance of Veterinary Antimicrobial Consumption), 2013. Revised ESVAC reflection paper on collecting data on consumption of antimicrobial agents per animal species, on technical units of measurement and indicators for reporting consumption of antimicrobial agents in animals (EMA\/286416\/2012\u2010Rev.1). 29 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/12\/WC500136456.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref34","unstructured":"EMA\/ESVAC (European Medicines Agency\/European Surveillance of Veterinary Antimicrobial Consumption), 2016. Sales of veterinary antimicrobial agents in 29 EU\/EEA countries in 2014 (EMA\/61769\/2016). Trends from 2011 to 2014. Sixth ESVAC report. 176 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2016\/10\/WC500214217.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref35","unstructured":"EMA\/ESVAC (European Medicines Agency\/Committee for Medicinal Products for Veterinary Use), 2017. Guidance on provision of data on antimicrobial use by animal species from national data collection systems (EMA\/489035\/2016). 36 pp. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2017\/03\/WC500224492.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended\u2010spectrum beta\u2010lactamase\u2010producing organisms","volume":"73","author":"Falagas","year":"2009","journal-title":"Journal of Hospital Infection"},{"key":"10.2903\/j.efsa.2017.5017_ref37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fmicb.2016.01017","article-title":"Dissimilar fitness associated with resistance to fluoroquinolones influences clonal dynamics of various multiresistant bacteria","volume":"7","author":"Fuzi","year":"2016","journal-title":"Frontiers in Microbiology"},{"key":"10.2903\/j.efsa.2017.5017_ref38","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dku180","article-title":"Characterization of extended\u2010spectrum beta\u2010lactamase (ESBL)\u2010producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third\u2010or fourth\u2010generation cephalosporins","volume":"69","author":"Hammerum","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref39","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/AAC.02892-14","article-title":"Interaction between mutations and regulation of gene expression during development of De Novo antibiotic resistance","volume":"58","author":"Handel","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref40","doi-asserted-by":"crossref","first-page":"e0123039","DOI":"10.1371\/journal.pone.0123039","article-title":"Factors that affect transfer of the IncI1 beta\u2010lactam resistance plasmid pESBL\u2010283 between E.\u00a0coli strains","volume":"10","author":"Handel","year":"2015","journal-title":"PLoS ONE"},{"key":"10.2903\/j.efsa.2017.5017_ref41","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ajic.2006.05.228","article-title":"Managing methicillin\u2010resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms","volume":"34","author":"Henderson","year":"2006","journal-title":"American Journal of Infection Control"},{"key":"10.2903\/j.efsa.2017.5017_ref42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","article-title":"Antibiotic strategies in the era of multidrug resistance","volume":"20","author":"Karam","year":"2016","journal-title":"Critical Care"},{"key":"10.2903\/j.efsa.2017.5017_ref43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic\u2010resistant streptococcus pneumoniae in pre\u2010 and post\u2010conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clinical Microbiology Reviews"},{"key":"10.2903\/j.efsa.2017.5017_ref44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2807\/1560-7917.ES.2016.21.26.30266","article-title":"Antibiotic prescribing and expenditures in outpatient adults in Greece, 2010 to 2013: evidence from real\u2010world practice","volume":"21","author":"Kourlaba","year":"2016","journal-title":"Eurosurveillance"},{"key":"10.2903\/j.efsa.2017.5017_ref45","doi-asserted-by":"crossref","unstructured":"ter Kuile BH, Kraupner N and Brul S, 2016. The risk of low concentrations of antibiotics in agriculture for resistance in human health care. FEMS Microbiology Letters, 363, pii: fnw210. https:\/\/doi.org\/10.1093\/femsle\/fnw210","DOI":"10.1093\/femsle\/fnw210"},{"key":"10.2903\/j.efsa.2017.5017_ref46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/jac\/dkr555","article-title":"Reduction of fluoroquinolone use is associated with a decrease in methicillin\u2010resistant Staphylococcus aureus and fluoroquinolone\u2010resistant Pseudomonas aeruginosa isolation rates: a 10\u2010year study","volume":"67","author":"Lafaurie","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13620-017-0085-x","article-title":"The RESET mindset model applied on decreasing antibiotic usage in dairy cattle in the Netherlands","volume":"70","author":"Lam","year":"2017","journal-title":"Irish Veterinary Journal"},{"key":"10.2903\/j.efsa.2017.5017_ref48","doi-asserted-by":"crossref","unstructured":"Laxminarayan R and Klugman KP, 2011. Communicating trends in resistance using a drug resistance index. British Medical Journal Open, 1, e000135. https:\/\/doi.org\/10.1136\/bmjopen-2011-000135","DOI":"10.1136\/bmjopen-2011-000135"},{"key":"10.2903\/j.efsa.2017.5017_ref49","unstructured":"MARAN (Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in The Netherlands), 2016. MARAN 2016 \u2010 monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2015. 218 pp. Available online: http:\/\/www.wur.nl\/upload_mm\/0\/b\/c\/433ca2d5-c97f-4aa1-ad34-a45ad522df95_92416_008804_NethmapMaran2016+TG2.pdf"},{"key":"10.2903\/j.efsa.2017.5017_ref50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ddtec.2014.02.001","article-title":"General principles of antibiotic resistance in bacteria","volume":"11","author":"Martinez","year":"2014","journal-title":"Drug Discovery Today. Technologies"},{"key":"10.2903\/j.efsa.2017.5017_ref51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhin.2015.10.001","article-title":"Impact of infection with extended\u2010spectrum beta\u2010lactamase\u2010producing Escherichia coli or Klebsiella species on outcome and hospitalization costs","volume":"92","author":"Maslikowska","year":"2016","journal-title":"Journal of Hospital Infection"},{"key":"10.2903\/j.efsa.2017.5017_ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2016.1263409","article-title":"A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009\u20132016)","volume":"13","author":"Moreira","year":"2017","journal-title":"Human Vaccines and Immunotherapeutics"},{"key":"10.2903\/j.efsa.2017.5017_ref53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vetmic.2014.02.038","article-title":"Antimicrobial resistance monitoring projects for zoonotic and indicator bacteria of animal origin: common aspects and differences between EASSA and EFSA","volume":"171","author":"Moyaert","year":"2014","journal-title":"Veterinary Microbiology"},{"key":"10.2903\/j.efsa.2017.5017_ref54","unstructured":"OIE (World Organisation for Animal Health), 2007. OIE list of antimicrobials of veterinary importance. 9 pp. Available online: https:\/\/www.oie.int\/doc\/ged\/D9840.pdf"},{"issue":"Suppl 4","key":"10.2903\/j.efsa.2017.5017_ref55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0213-005X(14)70170-3","article-title":"Evolution of carbapenemase\u2010producing Enterobacteriaceae at the global and national level: what should be expected in the future?","volume":"32","author":"Oteo","year":"2014","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"},{"key":"10.2903\/j.efsa.2017.5017_ref56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2807\/esm.10.09.00564-en","article-title":"Pneumococcal vaccination policy in Europe","volume":"10","author":"Pebody","year":"2005","journal-title":"Eurosurveillance"},{"key":"10.2903\/j.efsa.2017.5017_ref57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1389557514666140123145809","article-title":"Evolution of drug resistance: insight on TEM beta\u2010lactamases structure and activity and beta\u2010lactam antibiotics","volume":"14","author":"Pimenta","year":"2014","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"10.2903\/j.efsa.2017.5017_ref58","first-page":"957","article-title":"Public health risk of antimicrobial resistance transfer from companion animals","volume":"72","author":"Pomba","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijantimicag.2016.06.014","article-title":"A One Health approach to antimicrobial resistance surveillance: is there a business case for it?","volume":"48","author":"Queenan","year":"2016","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.2903\/j.efsa.2017.5017_ref60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/00071668.2013.763902","article-title":"Characteristics of ciprofloxacin and cephalosporin resistant Escherichia coli isolated from turkeys in Great Britain","volume":"54","author":"Randall","year":"2013","journal-title":"British Poultry Science"},{"key":"10.2903\/j.efsa.2017.5017_ref61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-2600(17)30110-8","article-title":"Effect of high\u2010valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study","volume":"5","author":"Savulescu","year":"2017","journal-title":"Lancet Respiratory Medicine"},{"key":"10.2903\/j.efsa.2017.5017_ref62","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a streptococci in Finland","volume":"337","author":"Seppala","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.2903\/j.efsa.2017.5017_ref63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jac\/dkt301","article-title":"Antibiotic prescribing for adults in ambulatory care in the USA, 2007\u201009","volume":"69","author":"Shapiro","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref64","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.1592\/phco.19.12.129S.31702","article-title":"Decreased antimicrobial resistance after changes in antibiotic use","volume":"19","author":"Smith","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.2903\/j.efsa.2017.5017_ref65","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jvp.12226","article-title":"The management of risk arising from the use of antimicrobial agents in veterinary medicine in EU\/EEA countries \u2010 a review","volume":"38","author":"Torneke","year":"2015","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.2903\/j.efsa.2017.5017_ref66","volume-title":"Antimicrobial Resistance","author":"Venter","year":"2017"},{"key":"10.2903\/j.efsa.2017.5017_ref67","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ijmm.2014.07.015","article-title":"Subgrouping of ESBL\u2010producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs","volume":"304","author":"Valentin","year":"2014","journal-title":"International Journal of Medical Microbiology"},{"key":"10.2903\/j.efsa.2017.5017_ref68","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of Cross Mark 742 national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infectious Diseases"},{"key":"10.2903\/j.efsa.2017.5017_ref69","unstructured":"WHO (World Health Organization), 2005. Critically important antibacterial agents for human medicine for risk management strategies of non\u2010human use: report of a WHO working group consultation, 15 \u2010 18 February 2005. Canberra, Australia. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/43330\/1\/9241593601_eng.pdf?ua=1&ua=1"},{"key":"10.2903\/j.efsa.2017.5017_ref70","unstructured":"WHO (World Health Organization), 2017. Critically important antimicrobials for human medicine \u2010 5th revision 2016. Ranking of antimicrobial agents for risk management of antimicrobial resistance due to non\u2010human use. 48 pp. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/255027\/1\/9789241512220-eng.pdf"}],"container-title":["EFSA Journal"],"original-title":[],"link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2903\/j.efsa.2017.5017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.2903\/j.efsa.2017.5017\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T09:51:41Z","timestamp":1692179501000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.2903\/j.efsa.2017.5017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":70,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.2903\/j.efsa.2017.5017","relation":{},"ISSN":["1831-4732","1831-4732"],"issn-type":[{"value":"1831-4732","type":"print"},{"value":"1831-4732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}